We are live on ! Find out more
CI

CPMG Inc Portfolio holdings

AUM $37.1M
1-Year Est. Return 74.35%
This Fund
S&P 500
This Quarter Est. Return
-8.67%
1 Year Est. Return
+74.35%
3 Year Est. Return
+878.37%
5 Year Est. Return
+1,872.39%
10 Year Est. Return
–
AUM
$183M
AUM Growth
-$316M
Cap. Flow
-$295M
Cap. Flow %
-161.5%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
–
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$295M

Sector Composition

Rank Sector Weight
1 Healthcare 97.52%
2 Industrials 2.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRCT icon
1
Procept Biorobotics
PRCT
$1.09B
$175M 95.6%
5,328,867
– –
LUNR icon
2
Intuitive Machines
LUNR
$2.17B
$4.53M 2.48%
1,240,968
– –
TIL icon
3
Instil Bio
TIL
$50.3M
$3.52M 1.92%
410,923
– –
RETA
4
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
– –
-2,896,901
Closed -$295M

Similar funds

RH
Riverstone Holdings New York $36.9M AUM 80.85% 1-Year Est. Return
ICP
ION Crossover Partners Herzliya Pituach, Israel $36.9M AUM
GC
Gullane Capital Memphis, Tennessee $37.4M AUM 112.18% 1-Year Est. Return
PAWC
P.A.W. Capital Greenwich, Connecticut $36.7M AUM 6.81% 1-Year Est. Return
FC
Fiduciary Counselling Saint Paul, Minnesota $35.9M AUM 1.69% 1-Year Est. Return
BAM
BLKBRD Asset Management Old Greenwich, Connecticut $38.3M AUM 34.49% 1-Year Est. Return
CM
CoinFund Management New York $35.4M AUM
AP
Atairos Partners Bryn Mawr, Pennsylvania $35.2M AUM 32.88% 1-Year Est. Return

CPMG Inc's Q3 2023 Portfolio in Review

As of Q3 2023, CPMG Inc held 4 positions worth $183M, down 63% from $498M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

CPMG Inc withdrew a net $295M in Q3 2023, closing 1 position. Its most notable exit was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $295M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, down from 98% a quarter earlier, followed by Industrials.

  • CPMG Inc fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2023, selling an estimated $295M.
  • CPMG Inc's ten largest holdings make up 100% of its $183M portfolio in Q3 2023.
  • CPMG Inc opened 0 new positions and closed 1 in Q3 2023.
  • CPMG Inc's portfolio value fell 63% quarter-over-quarter to $183M.

Based on CPMG Inc's 13F filing for Q3 2023, filed 14 Nov 2023.